236 related articles for article (PubMed ID: 28741458)
1. Hybrid Polymeric-Magnetic Nanoparticles in Cancer Treatments.
Bonilla AM; Gonzalez PH
Curr Pharm Des; 2017; 23(35):5392-5402. PubMed ID: 28741458
[TBL] [Abstract][Full Text] [Related]
2. Bioactivity of Hybrid Polymeric Magnetic Nanoparticles and Their Applications in Drug Delivery.
Mohammed L; Ragab D; Gomaa H
Curr Pharm Des; 2016; 22(22):3332-52. PubMed ID: 26853596
[TBL] [Abstract][Full Text] [Related]
3. Functionalized Magnetic Nanostructures for Anticancer Therapy.
Teodor ED; Gatea F; Ficai A; Radu GL
Curr Drug Targets; 2018 Feb; 19(3):239-247. PubMed ID: 26853321
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Polymeric Nanocarriers as Robust Platforms for Cancer Therapy.
Elzoghby AO
Curr Pharm Des; 2017; 23(35):5211-5212. PubMed ID: 29110600
[No Abstract] [Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
7. Development and Characterization of Magnetite/Poly(butylcyanoacrylate) Nanoparticles for Magnetic Targeted Delivery of Cancer Drugs.
López-Viota M; El-Hammadi MM; Cabeza L; Prados J; Melguizo C; Ruiz Martinez MA; Arias JL; Delgado ÁV
AAPS PharmSciTech; 2017 Nov; 18(8):3042-3052. PubMed ID: 28508129
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
9. Magnetic nanoparticles based cancer therapy: current status and applications.
Zhang H; Liu XL; Zhang YF; Gao F; Li GL; He Y; Peng ML; Fan HM
Sci China Life Sci; 2018 Apr; 61(4):400-414. PubMed ID: 29675551
[TBL] [Abstract][Full Text] [Related]
10. Self-Assembled Nanocarriers Based on Amphiphilic Natural Polymers for Anti- Cancer Drug Delivery Applications.
Sabra S; Abdelmoneem M; Abdelwakil M; Mabrouk MT; Anwar D; Mohamed R; Khattab S; Bekhit A; Elkhodairy K; Freag M; Elzoghby A
Curr Pharm Des; 2017; 23(35):5213-5229. PubMed ID: 28552068
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional pH-sensitive polymeric nanoparticles for theranostics evaluated experimentally in cancer.
Liu Y; Feng L; Liu T; Zhang L; Yao Y; Yu D; Wang L; Zhang N
Nanoscale; 2014 Mar; 6(6):3231-42. PubMed ID: 24500240
[TBL] [Abstract][Full Text] [Related]
12. Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer.
Huang J; Qian W; Wang L; Wu H; Zhou H; Wang AY; Chen H; Yang L; Mao H
Int J Nanomedicine; 2016; 11():3087-99. PubMed ID: 27462153
[TBL] [Abstract][Full Text] [Related]
13. Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled Antitumor Drug Delivery.
Zeng J; Du P; Liu L; Li J; Tian K; Jia X; Zhao X; Liu P
Mol Pharm; 2015 Dec; 12(12):4188-99. PubMed ID: 26554495
[TBL] [Abstract][Full Text] [Related]
14. Lipid-coated polymeric nanoparticles for cancer drug delivery.
Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment.
Afsharzadeh M; Hashemi M; Mokhtarzadeh A; Abnous K; Ramezani M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1095-1110. PubMed ID: 28954547
[TBL] [Abstract][Full Text] [Related]
16. Magnetic nanoparticle-based drug delivery for cancer therapy.
Tietze R; Zaloga J; Unterweger H; Lyer S; Friedrich RP; Janko C; Pöttler M; Dürr S; Alexiou C
Biochem Biophys Res Commun; 2015 Dec; 468(3):463-70. PubMed ID: 26271592
[TBL] [Abstract][Full Text] [Related]
17. Superparamagnetic iron oxide nanoparticles (SPIONs): development, surface modification and applications in chemotherapy.
Mahmoudi M; Sant S; Wang B; Laurent S; Sen T
Adv Drug Deliv Rev; 2011; 63(1-2):24-46. PubMed ID: 20685224
[TBL] [Abstract][Full Text] [Related]
18. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
Zhang Y; Zhang P; Zhu T
Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
[TBL] [Abstract][Full Text] [Related]
19. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review.
Indoria S; Singh V; Hsieh MF
Int J Pharm; 2020 May; 582():119314. PubMed ID: 32283197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
